Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03887286 · ClinicalTrials.gov registry record · NA
Focused Cardiac Ultrasound
A NA study of Ventricular Dysfunction and Septal Defect, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 47
- Enrollment target
- 1
- Study location
NCT03887286 is a NA study of Ventricular Dysfunction and Septal Defect that has completed, run by University of Miami. The registered enrollment target is 47 participants, below the 197-participant average among 3 other Ventricular Dysfunction trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03887286, a NA study of Ventricular Dysfunction and Septal Defect, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 47 participants
- Enrollment target
- 1
- Study location
Study Summary
To compare the images from standard cardiac ultrasound with images from a small hand-held device; to find out more about the feasibility and accuracy of a small hand-held ultrasound device.
Conditions Studied
Interventions
- DEVICE Philips EPIQ 7 ultrasound machine
- DEVICE Philips Lumify Broadband sector array transducer
Study Locations (1)
Florida
- Jackson Memorial Hospital - Miami
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2019-04-01 |
| Est. Completion | 2019-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03887286
The ClinicalTrials.gov registry entry for NCT03887286 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 197-participant average among 3 other Ventricular Dysfunction trials with a reported enrollment target (76% lower). The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Ventricular Dysfunction appearing as the primary indexed condition, and to 2 interventions - of which Philips EPIQ 7 ultrasound machine is the first listed.
NCT03887286 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT03887286 about?
NCT03887286 is a clinical study titled "Focused Cardiac Ultrasound". To compare the images from standard cardiac ultrasound with images from a small hand-held device; to find out more about the feasibility and accuracy of a small hand-held ultrasound device.
What is the current status of trial NCT03887286?
This trial is currently completed. It is a NA study. The enrollment target is 47 participants. The study started on 2019-04-01. Estimated completion is 2019-05-30.
What conditions does trial NCT03887286 study?
This clinical trial studies the following conditions: Ventricular Dysfunction, Septal Defect, Pericardial Effusion, Valvular Disease.
What interventions are being tested in trial NCT03887286?
The interventions under investigation include: Philips EPIQ 7 ultrasound machine (DEVICE), Philips Lumify Broadband sector array transducer (DEVICE).
Who is sponsoring clinical trial NCT03887286?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03887286 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventricular Dysfunction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Thoratec HeartMate II Left Ventricular Assist System (LVAS) for Destination Therapy
COMPLETED · NA
-
Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)
RECRUITING
-
The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in Patients Undergoing LVAD Implantation
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.